Cargando…
Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports
BACKGROUND: The mortality rate of novel coronaviral disease (COVID-19) patients undergoing dialysis is considerably higher than that of patients with normal kidney function. As of August 2021, only remdesivir has been approved in Japan as an antiviral drug for the treatment of COVID-19. However, in...
Autores principales: | Ito, Jun, Kimura, Moritsugu, Toya, Tomoyuki, Isozumi, Konomi, Kawaji, Atsuro, Isozaki, Yudai, Fukagawa, Masafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996215/ https://www.ncbi.nlm.nih.gov/pubmed/35433033 http://dx.doi.org/10.1186/s41100-022-00404-9 |
Ejemplares similares
-
The Importance of Patient and Family Engagement, the Needs for Self-Monitoring of Blood Glucose (SMBG) – Our Perspectives Learned Through a Story of SMBG Assistive Devices Made by a Husband of the Patient with Diabetes
por: Kimura, Moritsugu, et al.
Publicado: (2022) -
A Survey on the Current Status of Ophthalmological Consultations in Patients With Diabetes Undergoing Maintenance Hemodialysis and the Effectiveness of Education on Consultation Behavior –Experience of a Single Hemodialysis Clinic in Japan
por: Kimura, Moritsugu, et al.
Publicado: (2022) -
Behavior Modification Maintenance with Long-Term Blood Glucose and Weight Management in Prader–Willi Syndrome Complicated with Diabetes: Team Management Approach Combined with Pharmacological Treatment
por: Kato, Eri, et al.
Publicado: (2019) -
Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients
por: Shigematsu, Takashi, et al.
Publicado: (2018) -
Safety and Tolerability of Remdesivir in Patients with End-stage Renal Disease on Maintenance Hemodialysis
por: Shah, Maulin K, et al.
Publicado: (2022)